DEUTSCHE BANK AG\ - STOKE THERAPEUTICS INC ownership

STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 108 filers reported holding STOKE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of STOKE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$54,222
-99.1%
13,762
-97.6%
0.00%
-100.0%
Q2 2023$6,064,532
+1.6%
570,511
-20.4%
0.00%0.0%
Q1 2023$5,971,919
-13.5%
716,917
-4.1%
0.00%
-25.0%
Q4 2022$6,902,065
-31.7%
747,786
-5.0%
0.00%
-33.3%
Q3 2022$10,104,000
-3.0%
786,885
-0.2%
0.01%0.0%
Q2 2022$10,415,000
+82.0%
788,381
+190.0%
0.01%
+100.0%
Q1 2022$5,723,000
+880.0%
271,886
+1017.4%
0.00%
Q4 2021$584,000
-15.7%
24,331
-10.5%
0.00%
Q3 2021$693,000
+63.8%
27,195
+116.4%
0.00%
Q2 2021$423,000
+20.2%
12,567
+38.6%
0.00%
Q1 2021$352,000
-38.2%
9,068
-1.5%
0.00%
Q4 2020$570,000
+153.3%
9,209
+36.7%
0.00%
Q3 2020$225,000
+54.1%
6,735
+9.6%
0.00%
Q2 2020$146,000
+8.1%
6,145
+4.0%
0.00%
Q1 2020$135,000
+48.4%
5,910
+81.8%
0.00%
Q4 2019$91,000
+54.2%
3,251
+15.1%
0.00%
Q3 2019$59,0002,8250.00%
Other shareholders
STOKE THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Skorpios Trust 14,443,681$56,908,10399.78%
Lynx1 Capital Management LP 1,710,154$6,738,0074.46%
COWEN AND COMPANY, LLC 3,721,659$14,663,3361.03%
Redmile Group, LLC 3,872,696$15,258,4220.73%
RTW INVESTMENTS, LP 4,390,558$17,298,7990.36%
Birchview Capital, LP 85,000$334,9000.28%
Cormorant Asset Management, LP 1,087,807$4,285,9600.25%
Granahan Investment Management 851,201$3,353,7320.12%
GSA CAPITAL PARTNERS LLP 348,069$1,3710.12%
Simplify Asset Management Inc. 102,985$405,7610.05%
View complete list of STOKE THERAPEUTICS INC shareholders